• About
  • Advertise
  • Privacy & Policy
  • Contact
Hindustan Chronicles
  • Home
  • News
  • Editor Spotlight
  • Brand Post
No Result
View All Result
  • Home
  • News
  • Editor Spotlight
  • Brand Post
No Result
View All Result
Hindustan Chronicles
No Result
View All Result
  • Home
  • News
  • Editor Spotlight
  • Brand Post

GSK Velu is FICCI T.N. Chair

Editor by Editor
January 28, 2022
in News
0
GSK Velu is FICCI T.N. Chair

[ad_1]

GSK Velu, chairman and managing director of Trivitron Group of Corporations and chairman – Neuberg Diagnostics, has been re-appointed chairman, FICCI Tamil Nadu State Council for the yr 2022. Mentor, Director and Shareholder, Kauvery Group of Hospitals and Honorary Consul to the Republic of Estonia in India, Mr. Velu is a serial healthcare entrepreneur.

Bhupesh Nagarajan, chairman and director of Indira Tasks Group of Corporations, and founder and director Indira Tasks, Singapore and Maldives, has been appointed as Co-Chairman.

[ad_2]

Source link

Previous Post

‘Ranjish Hello Sahi’ overview: Amala Paul shines on this recreation of Mahesh Bhatt’s universe

Next Post

Meta-Owned Messenger’s Finish-to-Finish Encrypted Chats Now Accessible to All

Editor

Editor

Next Post
Meta-Owned Messenger’s Finish-to-Finish Encrypted Chats Now Accessible to All

Meta-Owned Messenger’s Finish-to-Finish Encrypted Chats Now Accessible to All

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2022 Hindustan Chronicles - All Rights Reserved

Social icon element need JNews Essential plugin to be activated.
No Result
View All Result
  • Education
  • Entertainment
  • Lifestyle
  • News
  • Press Release
  • Reviews
  • Sports
  • Tech
  • Trending
  • Guest Post
  • About

© 2022 Hindustan Chronicles - All Rights Reserved

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.